These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2912719)

  • 1. Comparison of steady-state blood levels of two carbamazepine formulations.
    Jumao-as A; Bella I; Craig B; Lowe J; Dasheiff RM
    Epilepsia; 1989; 30(1):67-70. PubMed ID: 2912719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic bioequivalency study of brand name versus generic carbamazepine.
    Oles KS; Penry JK; Smith LD; Anderson RL; Dean JC; Riela AR
    Neurology; 1992 Jun; 42(6):1147-53. PubMed ID: 1603340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotherapy with conventional and controlled-release carbamazepine: a double-blind, double-dummy comparison in epileptic patients.
    McKee PJ; Blacklaw J; Butler E; Gillham RA; Brodie MJ
    Br J Clin Pharmacol; 1991 Jul; 32(1):99-104. PubMed ID: 1888646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breakthrough seizures with generic carbamazepine: a consequence of poorer bioavailability?
    Hartley R; Aleksandrowicz J; Ng PC; McLain B; Bowmer CJ; Forsythe WI
    Br J Clin Pract; 1990 Jul; 44(7):270-3. PubMed ID: 2206824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind crossover comparison of Tegretol-XR and Tegretol in patients with epilepsy. The Tegretol OROS Osmotic Release Delivery System Study Group.
    Neurology; 1995 Sep; 45(9):1703-7. PubMed ID: 7675230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of bioavailability and clinical efficacy of carbamazepine in epileptic patients.
    Silpakit O; Amornpichetkoon M; Kaojarern S
    Ann Pharmacother; 1997 May; 31(5):548-52. PubMed ID: 9161646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution and relative bioavailability of two carbamazepine preparations for children with epilepsy.
    Hartley R; Aleksandrowicz J; Bowmer CJ; Cawood A; Forsythe WI
    J Pharm Pharmacol; 1991 Feb; 43(2):117-9. PubMed ID: 1672895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
    Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE
    Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and cognitive effects of carbamazepine formulations with different dissolution rates.
    Aldenkamp AP; Rentmeester T; Hulsman J; Majoie M; Doelman J; Diepman L; Schellekens A; Franken M; Olling M
    Eur J Clin Pharmacol; 1998 Apr; 54(2):185-92. PubMed ID: 9626926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic evaluation of twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy.
    Garnett WR; Levy B; McLean AM; Zhang Y; Couch RA; Rudnic EM; Pellock JM; Belendiuk GW
    Epilepsia; 1998 Mar; 39(3):274-9. PubMed ID: 9578044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of conventional and controlled-release carbamazepine in healthy subjects.
    Larkin JG; McLellan A; Munday A; Sutherland M; Butler E; Brodie MJ
    Br J Clin Pharmacol; 1989 Mar; 27(3):313-22. PubMed ID: 2655682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind randomized study comparing brand-name and generic phenytoin monotherapy.
    Mikati M; Bassett N; Schachter S
    Epilepsia; 1992; 33(2):359-65. PubMed ID: 1547767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
    Powell G; Saunders M; Marson AG
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007124. PubMed ID: 20091617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.
    Brodie MJ; Fakhoury T; McDonough B; Colson AO; Stockis A; Elmoufti S; Whitesides J
    Epilepsy Res; 2018 Sep; 145():55-62. PubMed ID: 29908435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double dummy comparison between once and twice daily dosing with modified-release carbamazepine in epileptic patients.
    McKee PJ; Blacklaw J; Carswell A; Gillham RA; Brodie MJ
    Br J Clin Pharmacol; 1993 Sep; 36(3):257-61. PubMed ID: 9114913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy.
    Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M
    Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly.
    Saetre E; Perucca E; Isojärvi J; Gjerstad L;
    Epilepsia; 2007 Jul; 48(7):1292-302. PubMed ID: 17561956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial.
    Gupta M; Gupta YK; Agarwal S; Aneja S; Kalaivani M; Kohli K
    Epilepsia; 2004 Dec; 45(12):1636-9. PubMed ID: 15571523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is generic prescribing acceptable in epilepsy?
    Besag FM
    Drug Saf; 2000 Sep; 23(3):173-82. PubMed ID: 11005701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dosage frequency of carbamazepine on drug serum levels in epileptic patients.
    Ghose K; Fry DE; Christfides JA
    Eur J Clin Pharmacol; 1983; 24(3):375-81. PubMed ID: 6861851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.